Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.

Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.     PRESS RELEASE INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), a licensed producer under the Access to Cannabis for Medical Purposes
Complete Reading

Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update   FOREX INVESSTORS  PRESS RELEASE  Acreage Pharms Ltd   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes
Complete Reading

  Invictus MD completes acquisition of Acreage Pharms Ltd. a Licensed Producer of Cannabis under the ACMPR   BUZ INVESTORS PRESS RELEASE  Invictus MD completes acquisition  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has acquired 100% of the shares of Acreage
Complete Reading

Invictus MD announces $40,000,000 Bought Deal Private Placement of Convertible Debentures and notice of intention to exercise option on Acreage Pharms   BUZ INVESTORS  Invictus MD announces $40,000,000 Bought Deal INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announced today that it has engaged Canaccord Genuity Corp. and Eventus
Complete Reading

Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis   BUZ INVESTORS Invictus MD’s Acreage Pharms Begins Cultivation   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. (“Acreage Pharms”) which Invictus MD has the option to now acquire 100 percent
Complete Reading

Create Account



Log In Your Account